EuroPRevent 2012
CVD prevention experts will meet in Dublin from 3-5 May for the leading international forum for preventive cardiology, Finn Snyder reports.
Cardiovascular diseases
The PARTNER Trial
Cohort A and B Results. Aortic stenosis is characterised by the hardening and narrowing of the aortic valve that pumps blood into the body’s main artery. It affects nearly 5% of those over 75 in Europe, with an estimated 16,000 Britons suffering from severe aortic stenosis.
The Symetis Acurate TA Aortic Bioprosthesis and delivery system
A new transcatheter aortic valve implantation (TAVI) system for transapical treatment of severe aortic stenosis – Acurate TA and delivery system –is a second- generation TAVI device to treat elderly patients. Launched by the Swiss firm Symetis SA, the system gained CE approval last September is on sale in Europe.
Art improves stroke survivors' quality of life
Stroke survivors who like art have a significantly higher quality of life than those who do not, according to new research. Patients who appreciated music, painting and theatre recovered better from their stroke than patients who did not.
Peripheral arterial occlusive disease Long balloons are the gold standard
Every year, around 80,000 lower extremities in Europe have to be (partially) amputated as a result of peripheral arterial occlusive disease (PAOD). Half of the affected patients die within five years of the amputation.
New generation drug-eluting stents
A registry -which includes every patient in Sweden having percutaneous coronary intervention (PCI) for the treatment of acute and stable coronary artery disease- has found that PCI implantations using a new generation of drug-eluting stents is associated with lower rates of relapse (restenosis), stent thrombosis and subsequent mortality than older generation drug-eluting stents and bare-metal…
Congenital heart defects
The German Paediatric Heart Centre (DKHZ) is one of the largest of its kind in Europe. Over 25 years the centre has treated big and small patients with congenital heart defects, very now and then being faced with rare, individual cases that present very particular challenges. In any one year, consultant paediatric cardiologist Professor Martin Schneider MD encounters perhaps five such non-…
Article • Focus on TAVI
Transcatheder aortic valve implants
With transcatheder aortic valve implants (TAVI) forming some 20% of all heart valve replacement procedures today, and the technology constantly developing, the 'real art' to the intervention's success lies in precise patient selection and procedure performance carried out by a multi-disciplinary and effective team, according to Simon Redwood, Professor of the interventional cardiology at King's…
A niche with no lobby
Italy is a front runner in diabetic foot revascularisation. Among the country’s pioneers is Professor Roberto Gandini, at the Diagnostic Imaging and Interventional Radiology Department, University of Tor Vergata in Rome, who has developed and improved new technical options in peripheral vascular disease intervention, a technique that now saves about 92% of patients from major amputations due…
Coronary Heart Disease can be diagnosed and treated earlier using new techniques
Prof. Uwe Nixdorff from the European Prevention Centre, Düsseldorf advocates cardiologists combine IMT measurement with ALOKA’s pulse wave intensity function to check for unseen coronary heart disease: “This technique is currently seldom used, however in my experience it provides a more complete picture and enables me to treat patients earlier for life-threatening conditions that are often…
Sheffield Hospitals to work on prestigious heart failure research project
Researchers in Sheffield have been given an mportant grant to trial state-of-the-art computer modelling systems that could provide a breakthrough in the treatment of patients with heart failure.
Touch screen cardiopulmonary diagnostics
Schiller reports that its new range of touch screen ECG systems combines precision performance and attractive ergonomics. With a touch to the large, high-resolution colour display, 12-lead ECGs and pulmonary function tests can be recorded, selected and printed in seconds.
Congenital heart disease
New research carried out in the UK has revealed that young children with congenital heart disease are at risk of having harmful toxins in their blood, particularly following surgery. Mark Nicholls reports
Cardiac resynchronisation therapy
From guidelines to daily clinical practice: Cardiac resynchronisation therapy is increasingly important in heart failure treatment. The therapy is complex, the demands to medical technology high. Holger Zorn reports
ESC roundup: Fixing heart conditions
Devices to treat chronic cardiac disease are winning credibility with new evidence from large-scale patient registries, John Brosky reports
Civilisation Diseases breaking economic growth
More than 63% of all deaths in the world are caused by so- called non-communicable diseases. In the WHO-region of Europe it’s even higher – 86%. The direct and indirect economic costs are huge – to the point of posing a real threat to growth in crisis-hit economies. Therapy alone is not enough, World Bank strategist Dr. Armin Fidler told the European Health Forum Gastein. Effective…
It's official – chocolate linked to heart health
High levels of chocolate consumption might be associated with a one third reduction in the risk of developing heart disease, finds a study published on bmj.com. The findings confirm results of existing studies that generally agree on a potential beneficial link between chocolate consumption and heart health. However, the authors stress that further studies are needed to test whether chocolate…
MitraClip Therapy Demonstrates Benefits
Results of an observational study presented at the European Society of Cardiology (ESC) meeting in Paris demonstrate that the percutaneous catheter-based MitraClip treatment improves symptoms and promotes reverse left ventricular (LV) remodeling in patients with mitral regurgitation (MR), who do not respond to cardiac resynchronization therapy (CRT).
What do patients receiving optimal medical therapy after a heart attack die from?
Because of improved management at the acute stage, the risk of dying in hospital after a heart attack has decreased by about 50% in the past 10 years. Likewise, the prescription of recommended medications when patients leave hospital, has resulted in improved survival and fewer recurrent heart attacks.
Cardiac Disease: Coronary or not?
Acute myocardial Infarction (AMI) is a major cause of death and disability. Worldwide, one in eight patients die of an ischemic heart disease. Its rapid and accurate diagnosis is critical for the initiation of effective evidence based medical management, including early revascularization, but is still an unmet clinical need. The gradual implementation of high-sensitive cardiac troponins (hs-cTnT)…
The PRODIGY study
However, the PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY (PRODIGY) also found a consistently greater risk of haemorrhage in the 24-month dual therapy group according to all prespecified bleeding definitions, including the recently proposed Bleeding Academic Research Consortium classification. The need for transfusion was also increased in the…
Philips and Innovations in Heart Modeling*
Royal Philips Electronics provided clinicians from across the globe with a glimpse of future innovations designed to advance cardiac care, including the current management of cardiovascular disease (CVD) and associated cardiac conditions, during the 2011 Congress of the European Society of Cardiology (ESC).
Solutions for Sustainable Cardiovascular Care
Siemens Healthcare presented solutions for sustainable cardiovascular care at the European Society of Cardiology (ESC) congress in Paris, France, under the motto "Are you ready for the long run?". This includes all modern imaging technologies, in-vitro diagnostics, IT solutions and consulting services.
RESPONSE trial results
Studies show that when a nurse follows patients after a cardiovascular crisis those patients stay healthier, live longer and reduce the risk of returning to hospital. Now the challenge is how to convince insurers to pay for this care, reports John Brosky.
Transcatheter aortic valve implants
Although transcatheter aortic valve implantation (TAVI) is increasingly the most used surgical procedure in Germany, only two products have been approved for routine use. Although this has prompted other medical device manufacturers to go into action, according to Professor Justus Strauch, head of cardiac surgery at the Klinikum Bergmannsheil, Bochum, no one has yet taken the lead in this…
